<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Iradimed Corporation — News on 6ix</title>
<link>https://6ix.com/company/iradimed-co</link>
<description>Latest news and press releases for Iradimed Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 20 May 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/iradimed-co" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683584f978dffbe2df0fd532.webp</url>
<title>Iradimed Corporation</title>
<link>https://6ix.com/company/iradimed-co</link>
</image>
<item>
<title>IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference</guid>
<pubDate>Wed, 20 May 2026 12:30:00 GMT</pubDate>
<description>ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida. Investors interested in meeting with Iradimed management during the conference may</description>
</item>
<item>
<title>IRADIMED CORPORATION Reports First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-first-quarter-2026-financial-results</guid>
<pubDate>Fri, 01 May 2026 04:00:00 GMT</pubDate>
<description>Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $22.0 million for the</description>
</item>
<item>
<title>IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-hold-first-quarter-2026-financial-results-conference-call-on-may-1-2026</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-hold-first-quarter-2026-financial-results-conference-call-on-may-1-2026</guid>
<pubDate>Mon, 27 Apr 2026 12:30:00 GMT</pubDate>
<description>ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.co</description>
</item>
<item>
<title>IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-participate-at-the-25th-annual-needham-virtual-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-participate-at-the-25th-annual-needham-virtual-healthcare-conference</guid>
<pubDate>Fri, 10 Apr 2026 19:14:00 GMT</pubDate>
<description>ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed’s CFO, Jack Glenn, will host one-on-one meetings with investors at the 25th Annual Needham Virtual Healthcare Conference, which is scheduled to take place from April 13-16, 2026. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compati</description>
</item>
<item>
<title>IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-participate-at-the-38th-annual-roth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-to-participate-at-the-38th-annual-roth-conference</guid>
<pubDate>Mon, 16 Mar 2026 04:00:00 GMT</pubDate>
<description>ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38th Annual Roth</description>
</item>
<item>
<title>IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-record-fourth-130000481</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-record-fourth-130000481</guid>
<pubDate>Tue, 10 Feb 2026 13:00:00 GMT</pubDate>
<description>Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP diluted EPS of $0.54 for the fourth quarter of 2025, which are increases of 25% and 23%, respectively, compared to the same period in 2024. Reports record GAAP diluted EPS of $1.75 and non-GAAP diluted EPS of $1.93 for the full year of 2025, which are increases of 17% and 16%, respectively, compared</description>
</item>
<item>
<title>IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-fourth-quarter-210500623</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-fourth-quarter-210500623</guid>
<pubDate>Wed, 04 Feb 2026 21:05:00 GMT</pubDate>
<description>ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market opens on Tuesday, February 10, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register</description>
</item>
<item>
<title>IRADIMED Announces Special Cash Dividend of $0.50 Per Share</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-announces-special-cash-dividend-050-share-2025-12-08</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-announces-special-cash-dividend-050-share-2025-12-08</guid>
<pubDate>Mon, 08 Dec 2025 05:00:00 GMT</pubDate>
<description>ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”)</description>
</item>
<item>
<title>IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-named-times-list-americas-growth-leaders-2026-2025-11-10</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-named-times-list-americas-growth-leaders-2026-2025-11-10</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION</description>
</item>
<item>
<title>IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-record-third-quarter-2025-financial-results-2025-11-03</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-record-third-quarter-2025-financial-results-2025-11-03</guid>
<pubDate>Mon, 03 Nov 2025 05:00:00 GMT</pubDate>
<description>Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance Reports record revenue of $21.2 million for the third quarter of</description>
</item>
<item>
<title>IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-third-quarter-2025-financial-results-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-third-quarter-2025-financial-results-conference-call</guid>
<pubDate>Mon, 27 Oct 2025 04:00:00 GMT</pubDate>
<description>ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter</description>
</item>
<item>
<title>IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-announces-board-transition-anthony-vuoto-retires-joe-kiani</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-announces-board-transition-anthony-vuoto-retires-joe-kiani</guid>
<pubDate>Tue, 02 Sep 2025 04:00:00 GMT</pubDate>
<description>ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed” or the “Company”) (NASDAQ: IRMD), a leader in innovative medical devices</description>
</item>
<item>
<title>IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-participate-2025-wells-fargo-healthcare-conference-2025-08-26</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-participate-2025-wells-fargo-healthcare-conference-2025-08-26</guid>
<pubDate>Tue, 26 Aug 2025 04:00:00 GMT</pubDate>
<description>ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging</description>
</item>
<item>
<title>IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-record-second-quarter-2025-financial-results-2025-08-01</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-reports-record-second-quarter-2025-financial-results-2025-08-01</guid>
<pubDate>Fri, 01 Aug 2025 04:00:00 GMT</pubDate>
<description>Announces Regular Quarterly Cash Dividend of $0.17 Per Share Raises Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $20.4 million for</description>
</item>
<item>
<title>IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-second-quarter-2025-financial-results-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-second-quarter-2025-financial-results-conference-call</guid>
<pubDate>Fri, 25 Jul 2025 04:00:00 GMT</pubDate>
<description>ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter</description>
</item>
<item>
<title>IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-announces-fda-510k-clearance-mridiumr-3870-infusion-pump-system</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-announces-fda-510k-clearance-mridiumr-3870-infusion-pump-system</guid>
<pubDate>Thu, 29 May 2025 04:00:00 GMT</pubDate>
<description>WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI</description>
</item>
<item>
<title>IRADIMED CORPORATION Announces First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-announces-first-quarter-2025-financial-results-2025-05-05</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-announces-first-quarter-2025-financial-results-2025-05-05</guid>
<pubDate>Mon, 05 May 2025 04:00:00 GMT</pubDate>
<description>Announces Regular Quarterly Cash Dividend of $0.17 Per Share Reaffirms Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $19.5 million</description>
</item>
<item>
<title>CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025</title>
<link>https://6ix.com/company/iradimed-co/news/correction-iradimed-corporation-hold-first-135300379</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/correction-iradimed-corporation-hold-first-135300379</guid>
<pubDate>Mon, 28 Apr 2025 13:53:00 GMT</pubDate>
<description>WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by IRADIMED CORPORATION (NASDAQ: IRMD), please note that in the first paragraph the date of the earnings call should read "Monday, May 5, 2025" instead of "Friday, May 5, 2025". The corrected release follows: IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first quarter financial results before the market opens on Monday, May 5, 2025. Iradi</description>
</item>
<item>
<title>IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-first-quarter-2025-financial-results-conference-call-may-5</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-hold-first-quarter-2025-financial-results-conference-call-may-5</guid>
<pubDate>Mon, 28 Apr 2025 04:00:00 GMT</pubDate>
<description>WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first</description>
</item>
<item>
<title>IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference</title>
<link>https://6ix.com/company/iradimed-co/news/iradimed-corporation-participate-37th-annual-roth-conference-2025-03-10</link>
<guid isPermaLink="true">https://6ix.com/company/iradimed-co/news/iradimed-corporation-participate-37th-annual-roth-conference-2025-03-10</guid>
<pubDate>Mon, 10 Mar 2025 04:00:00 GMT</pubDate>
<description>WINTER SPRINGS, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the</description>
</item>
</channel>
</rss>